ARYA Sciences Acquisition IV Stock Price, News & Analysis

ARYD NASDAQ

Company Description

Welcome to the overview page for ARYA Sciences Acquisition IV (ARYD), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100 %

Performance 1 year

$50.0M

Market Cap

3.8M

Shares outstanding

Latest News

View All

August 19, 2024

3.94%

Adagio Medical Provides Business Updates

July 31, 2024

36.30%

Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias

February 14, 2024

0.90%

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

acquisition clinical trial

February 24, 2022

1.41%

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

acquisition

February 26, 2021

0.00%

ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering

IPO offering acquisition

SEC Filings

View All

No SEC filings available for ARYA Sciences Acquisition IV.

Financial Highlights

-$245,847

Net Income (TTM)

-$511,686

Operating Cash Flow

0.01

Current Ratio

-$611,740

Operating Income

—

Revenue (TTM)

—

Diluted EPS (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of ARYA Sciences Acquisition IV (ARYD)?

The current stock price of ARYA Sciences Acquisition IV (ARYD) is $11.54 as of February 7, 2025.

What is the market cap of ARYA Sciences Acquisition IV (ARYD)?

The market cap of ARYA Sciences Acquisition IV (ARYD) is approximately 50.0M. Learn more about what market capitalization means .

What is the net income of ARYA Sciences Acquisition IV (ARYD)?

The trailing twelve months (TTM) net income of ARYA Sciences Acquisition IV (ARYD) is -$245,847.

What is the operating cash flow of ARYA Sciences Acquisition IV (ARYD)?

The operating cash flow of ARYA Sciences Acquisition IV (ARYD) is -$511,686. Learn about cash flow.

What is the current ratio of ARYA Sciences Acquisition IV (ARYD)?

The current ratio of ARYA Sciences Acquisition IV (ARYD) is 0.01, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of ARYA Sciences Acquisition IV (ARYD)?

The operating income of ARYA Sciences Acquisition IV (ARYD) is -$611,740. Learn about operating income.